1. Market Research
  2. > Alzinova AB - Product Pipeline Review - 2013

Alzinova AB - Product Pipeline Review - 2013

  • September 2013
  • -
  • Global Markets Direct
  • -
  • 21 pages

Alzinova AB - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Alzinova AB - Product Pipeline Review - 2013” provides data on the Alzinova AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Alzinova AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Alzinova AB and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Alzinova AB - Brief Alzinova AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Alzinova AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Alzinova AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Alzinova AB’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Alzinova AB’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Alzinova AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Alzinova AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Alzinova AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Alzinova AB and identify potential opportunities in those areas.

Table Of Contents

Alzinova AB - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Alzinova AB Snapshot 4
Alzinova AB Overview 4
Key Information 4
Key Facts 4
Alzinova AB - Research and Development Overview 5
Key Therapeutic Areas 5
Alzinova AB - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Alzinova AB - Pipeline Products Glance 9
Alzinova AB - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Alzinova AB - Drug Profiles 11
ALZ-101 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
ALZ-102 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
ALZ-103 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
ALZ-201 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
ALZ-301 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Alzinova AB - Pipeline Analysis 16
Alzinova AB - Pipeline Products by Therapeutic Class 16
Alzinova AB - Pipeline Products By Target 17
Alzinova AB - Pipeline Products By Mechanism of Action 18
Alzinova AB - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
Coverage 20
Secondary Research 20
Primary Research 20
Expert Panel Validation 20
Contact Us 21
Disclaimer 21



List of Tables

Alzinova AB, Key Information 4
Alzinova AB, Key Facts 4
Alzinova AB - Pipeline by Indication, 2013 6
Alzinova AB - Pipeline by Stage of Development, 2013 7
Alzinova AB - Monotherapy Products in Pipeline, 2013 8
Alzinova AB - Preclinical, 2013 9
Alzinova AB - Discovery, 2013 10
Alzinova AB - Pipeline By Therapeutic Class, 2013 16
Alzinova AB - Pipeline By Target, 2013 17
Alzinova AB - Pipeline Products By Mechanism of Action, 2013 18



List of Figures

Alzinova AB - Pipeline by Indication, 2013 6
Alzinova AB - Pipeline by Stage of Development, 2013 7
Alzinova AB - Monotherapy Products in Pipeline, 2013 8
Alzinova AB - Pipeline By Therapeutic Class, 2013 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.